These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 10734317)
1. M6P/IGF2R is mutated in squamous cell carcinoma of the lung. Kong FM; Anscher MS; Washington MK; Killian JK; Jirtle RL Oncogene; 2000 Mar; 19(12):1572-8. PubMed ID: 10734317 [TBL] [Abstract][Full Text] [Related]
2. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan. Oka Y; Waterland RA; Killian JK; Nolan CM; Jang HS; Tohara K; Sakaguchi S; Yao T; Iwashita A; Yata Y; Takahara T; Sato S; Suzuki K; Masuda T; Jirtle RL Hepatology; 2002 May; 35(5):1153-63. PubMed ID: 11981765 [TBL] [Abstract][Full Text] [Related]
3. M6P/IGF2 receptor: a candidate breast tumor suppressor gene. Hankins GR; De Souza AT; Bentley RC; Patel MR; Marks JR; Iglehart JD; Jirtle RL Oncogene; 1996 May; 12(9):2003-9. PubMed ID: 8649861 [TBL] [Abstract][Full Text] [Related]
4. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. De Souza AT; Hankins GR; Washington MK; Orton TC; Jirtle RL Nat Genet; 1995 Dec; 11(4):447-9. PubMed ID: 7493029 [TBL] [Abstract][Full Text] [Related]
5. Genetic changes and expression of the mannose 6-phosphate/insulin-like growth factor II receptor gene in human hepatitis B virus-associated hepatocellular carcinoma. Yang EB; Qin LL; Zhao YN; Zhang K; Chow P Int J Mol Med; 2003 Jun; 11(6):773-8. PubMed ID: 12736721 [TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer. Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury. Kong FM; Anscher MS; Sporn TA; Washington MK; Clough R; Barcellos-Hoff MH; Jirtle RL Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):35-41. PubMed ID: 11163495 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential. Xie S; Kang JX Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733 [TBL] [Abstract][Full Text] [Related]
9. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers. Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478 [TBL] [Abstract][Full Text] [Related]
10. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan. Wada I; Kanada H; Nomura K; Kato Y; Machinami R; Kitagawa T Hepatology; 1999 Jun; 29(6):1718-21. PubMed ID: 10347113 [TBL] [Abstract][Full Text] [Related]
11. Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations. Killian JK; Oka Y; Jang HS; Fu X; Waterland RA; Sohda T; Sakaguchi S; Jirtle RL Hum Mutat; 2001; 18(1):25-31. PubMed ID: 11438990 [TBL] [Abstract][Full Text] [Related]
12. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors. Mills JJ; Falls JG; De Souza AT; Jirtle RL Oncogene; 1998 May; 16(21):2797-802. PubMed ID: 9652747 [TBL] [Abstract][Full Text] [Related]
13. High throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancer. Huang Z; Wen Y; Shandilya R; Marks JR; Berchuck A; Murphy SK Nucleic Acids Res; 2006; 34(2):555-63. PubMed ID: 16432260 [TBL] [Abstract][Full Text] [Related]
14. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. De Souza AT; Hankins GR; Washington MK; Fine RL; Orton TC; Jirtle RL Oncogene; 1995 May; 10(9):1725-9. PubMed ID: 7753549 [TBL] [Abstract][Full Text] [Related]
15. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer. Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232 [TBL] [Abstract][Full Text] [Related]
16. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids. Kang JX; Bell J; Beard RL; Chandraratna RA Cell Growth Differ; 1999 Aug; 10(8):591-600. PubMed ID: 10470859 [TBL] [Abstract][Full Text] [Related]
17. M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis. Jamieson TA; Brizel DM; Killian JK; Oka Y; Jang HS; Fu X; Clough RW; Vollmer RT; Anscher MS; Jirtle RL BMC Cancer; 2003 Feb; 3():4. PubMed ID: 12589712 [TBL] [Abstract][Full Text] [Related]
18. Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis. Martin-Kleiner I; Gall Troselj K Cancer Lett; 2010 Mar; 289(1):11-22. PubMed ID: 19646808 [TBL] [Abstract][Full Text] [Related]
19. Structural insights into the interaction of insulin-like growth factor 2 with IGF2R domain 11. Williams C; Rezgui D; Prince SN; Zaccheo OJ; Foulstone EJ; Forbes BE; Norton RS; Crosby J; Hassan AB; Crump MP Structure; 2007 Sep; 15(9):1065-78. PubMed ID: 17850746 [TBL] [Abstract][Full Text] [Related]
20. The mannose 6-phosphate-binding sites of M6P/IGF2R determine its capacity to suppress matrix invasion by squamous cell carcinoma cells. Probst OC; Karayel E; Schida N; Nimmerfall E; Hehenberger E; Puxbaum V; Mach L Biochem J; 2013 Apr; 451(1):91-9. PubMed ID: 23347038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]